International Business News - MAXY http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Biotechnology company Maxygen Inc. on Friday said it entered a partnership with Astellas Pharma Inc. of Japan to help develop and market its Maxy-4 drug candidates in autoimmune diseases. http://www.ibtimes.com/articles/20080919/maxygen-licenses-immune-drugs-to-astellas-pharma.htm Fri, 19 Sep 2008 07:08:26 EDT Among the stock activity stories for Wednesday, July 2, from AP Financial News: NEW YORK (AP)--Shares of jams and jellies maker J.M. Smucker Co. jumped Wednesday after a Deutsche Bank analyst boosted his rating in the stock, saying profit should improve in 2009. http://www.ibtimes.com/articles/20080702/movers-roundup-j-m-smucker-maxygen.htm Wed, 02 Jul 2008 14:43:26 EDT Shares of Maxygen Inc. jumped Wednesday after the biotechnology company said it is selling its hemophilia treatment program to Bayer's health care division for $90 million, plus up to $30 million in future milestone payments. http://www.ibtimes.com/articles/20080702/maxygen-shares-jump-on-bayer-hemophilia-deal.htm Wed, 02 Jul 2008 18:10:20 EDT Bayer's health care unit is buying Maxygen Inc.'s hemophilia unit for $90 million upfront and potential future fees of up to $30 million in a move to expand its specialty pharmaceutical business, the companies said Wednesday. http://www.ibtimes.com/articles/20080702/maxygen-selling-hemophilia-unit-to-bayer.htm Wed, 02 Jul 2008 10:07:09 EDT Among the stock activity stories for Monday, June 16, from AP Financial News: NEW YORK (AP)--Shares of Pier 1 Imports Inc. rose Monday after Cost Plus Inc. rejected the home products retailer's $88 million takeover bid. http://www.ibtimes.com/articles/20080616/movers-roundup-pier-1-maxygen.htm Mon, 16 Jun 2008 14:38:28 EDT Shares of Maxygen Inc. bounced back from a sharp decline, and an analyst said Monday that investors overreacted to a patent threat to its drug candidate MAXY-G34. http://www.ibtimes.com/articles/20080616/maxygen-edges-up-after-patent-induced-sell-off.htm Mon, 16 Jun 2008 12:11:20 EDT Maxygen Inc. warned Friday that Amgen Inc. may sue the company for patent infringement relating to Maxygen's Maxy-G34 drug candidate. Maxy-G34 is designed to be the improved version of granulocyte colony-stimulating factor, or G-CSF, for the treatment of neutropenia, according to a Securities and Exchange Commission filing Friday. http://www.ibtimes.com/articles/20080613/maxygen-warns-of-possible-amgen-suit.htm Fri, 13 Jun 2008 11:24:18 EDT Shares of Maxygen Inc. plunged 28 percent Friday, after the biotechnology company said it may be open to patent infringement litigation from rival Amgen Inc. http://www.ibtimes.com/articles/20080613/maxygen-plunges-on-potential-amgen-patent-dispute.htm Fri, 13 Jun 2008 19:35:49 EDT